- Report
- August 2024
- 111 Pages
Global
From €4162EUR$4,650USD£3,636GBP
- Report
- March 2024
- 145 Pages
Global
From €4162EUR$4,650USD£3,636GBP
- Report
- January 2023
- 131 Pages
Global
From €2238EUR$2,500USD£1,955GBP
- Report
- August 2023
- 180 Pages
Global
From €5326EUR$5,950USD£4,652GBP
- Report
- January 2025
- 160 Pages
Global
From €2676EUR$2,990USD£2,338GBP
- Report
- March 2025
Global
From €4386EUR$4,900USD£3,831GBP
- Report
- February 2025
- 287 Pages
Global
From €4923EUR$5,500USD£4,300GBP
- Report
- January 2025
- 142 Pages
Asia Pacific
From €2909EUR$3,250USD£2,541GBP
- Report
- September 2024
- 106 Pages
Global
From €4923EUR$5,500USD£4,300GBP
- Report
- April 2024
- 138 Pages
Global
From €4431EUR$4,950USD£3,870GBP
- Report
- February 2024
- 67 Pages
Europe
From €2641EUR$2,950USD£2,307GBP
- Report
- February 2024
- 77 Pages
Asia Pacific
From €2641EUR$2,950USD£2,307GBP
- Report
- January 2024
- 93 Pages
Europe
From €2641EUR$2,950USD£2,307GBP
- Report
- June 2023
- 361 Pages
Global
From €2462EUR$2,750USD£2,150GBP
€4923EUR$5,500USD£4,300GBP
- Report
- December 2021
- 296 Pages
Global
From €2350EUR$2,625USD£2,052GBP
€4699EUR$5,250USD£4,105GBP
- Report
- January 2023
- 103 Pages
Global
From €4431EUR$4,950USD£3,870GBP
- Report
- November 2022
- 54 Pages
Global
- Report
- September 2022
- 62 Pages
Global
From €4431EUR$4,950USD£3,870GBP
- Report
- June 2021
- 77 Pages
Global
From €4431EUR$4,950USD£3,870GBP
- Report
- May 2024
- 129 Pages
Global
From €3580EUR$3,999USD£3,127GBP

Gene Editing is a technology used in genomics to modify the genetic material of living organisms. It is used to make changes to the DNA sequence of a gene, such as deleting, inserting, or replacing a gene. This technology has been used to create genetically modified organisms, which have been used in research and medical applications. It has also been used to create gene therapies, which are treatments that use gene editing to modify a patient's genetic material to treat a disease.
Gene Editing is a rapidly growing market, with many companies developing new technologies and applications. Companies such as Editas Medicine, CRISPR Therapeutics, Intellia Therapeutics, and Sangamo Therapeutics are leading the way in developing gene editing technologies and treatments. Other companies such as Cellectis, Caribou Biosciences, and Twist Bioscience are also developing gene editing technologies and products. Show Less Read more